Saturday, July 25, 2026

pharma · Scabies · Bioequivalence trial in healthy volunteers

Alphapharm

Alphapharm patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU HQ
1982 Founded
187 Employees
TGA registrant Type
Company details
Status
Public
HQ
Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point, NSW 2000, AU
Founded
1982
Employees
187
Programs
1
Drugs
217
Patents
1
Intelligence · Patents

Alphapharm patents

1 pharmaceutical patents indexed for Alphapharm. 0 expire within 24 months.

Alphapharm has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. CA 2712282

    COMPOSITION PHARMACEUTIQUE DE DULOXETINE A LIBERATION RETARDEE

    Expires Wed Jul 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Alphapharm have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Alphapharm patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.